latest news releases from the newsroom
MEDIA ADVISORY -- CEVA to Present at Needham Growth Conference
DUBLIN, Jan. 6, 2004 (PRIMEZONE) -- Media Advisory -- CEVA, Inc. (Nasdaq:CEVA) (LSE:CVA), the industry's leading licensor of Digital Signal Processor (DSP) cores and solutions to the semiconductor industry, today announced that Chet Silvestri, CEO, and Christine Russell, CFO, will be present at the sixth annual Needham Growth Conference on Friday, January 9th, at the New York Palace Hotel, New York.
Humana Trans Unit Signs Definitive Acquisition Agreement
HANOVER, Md., Jan. 6, 2004 (PRIMEZONE) -- Humana Trans Services Holding Corporation (OTCBB:HTSC) (www.humanaservices.com), a principally engaged firm involved in employee leasing and recruitment services, is pleased to announce that the firm's operating subsidiary Humana National Program Administrators has proceeded on its intention to acquire Stratford, CT.-based Personnel Management Solutions, a firm involved in temp-to-perm staffing and payroll administration.
Celltech Group plc
Celltech Group plc Announces Initiation of CDP870 Phase III Trials in Crohn's Disease
SLOUGH, U.K., Jan. 5, 2004 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announces that it commenced dosing of patients in the first of two pivotal Phase III studies ("PRECISE-1") for CDP870 in Crohn's disease on 23 December 2003, following its U.S. investigator meeting held on 22 November. The second pivotal study ("PRECISE-2 ") is scheduled to start in January 2004, with regulatory submissions planned for 2005. Celltech intends to market CDP870 in Crohn's disease using its gastroenterology focused sales force in the US and specialist focused sales forces in Europe.
Discovery Laboratories, Inc.
Discovery Laboratories to Present at the 22nd Annual JP Morgan Healthcare Conference
DOYLESTOWN, Pa., Jan. 5, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biopharmaceutical company developing its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory diseases, today announced that Robert J. Capetola, Ph.D., President and Chief Executive Officer of Discovery, will provide an update on the company's progress during the 22nd Annual JP Morgan Healthcare Conference in San Francisco. The conference will be simultaneously webcast over the Internet.
ViaStar Holdings, Inc.
Recording Begins for Legendary Platinum Songwriter/Producer Gardner Cole's Greatest Hits
PHOENIX, Jan. 5, 2004 (PRIMEZONE) -- Viastar Holdings Inc. (OTCBB:VISH) announced today that recording for Gardner Cole's new release entitled "Gardner Cole, Past to Present" has commenced at the Company's A.V.O. Studios in Mesa, Arizona. As previously announced (see December 18th, 2003 press release), the album will include top 10 singles such as "Open Your Heart," the number one hit originally recorded by Madonna, "Everything" originally recorded by Jody Watley which charted at No. 3 on Billboard's top ten and "Another Lover," the title song from the hit Tri-Star release, "Loverboy". The company will begin retail solicitation second quarter of 2004 and is planning for an early July street date.
Dobson Communications Corporation
Dobson Communications Chairman to Present at CJS Securities Conference
OKLAHOMA CITY, Jan. 5, 2004 (PRIMEZONE) -- Dobson Communications Corporation (Nasdaq:DCEL) plans to present Wednesday, January 7, 2004, at the CJS Securities 4th Annual "New Ideas for the New Year" Investor Conference in New York City. The presentation by Everett Dobson, chairman, chief executive officer and president, is scheduled for 11 a.m. ET and will include an overview of Dobson's growth strategy and operating results through the third quarter ended September 30, 2003.